Skip to Content

08. February 2012

FDA grants Roche's pertuzumab Priority Review for previously untreated HER2-positive metastatic breast cancer

Roche today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application for pertuzumab and granted Priority Review. more

Media: News and Press Releases

Media Releases

All Media Releases

Roche in the Media

August 31, 2011

Roche to maintain lead in targeted drugs

Roche expects a new generation of drugs targeted at specific groups of patients to make up half its portfolio in 10 years, a shift that is pushing the boundaries of modern medicine. (Reuters.com)

August 22, 2011

A healthy forecast for pharma

Dow Jones Interview with Severin Schwan

more articles